GJE client Lundbeckfonden Emerge co-invests $50 million in SNIPR Biome Limited

On 11 March 2019, Lundbeckfonden Emerge announced the completion of a joint $50 million investment in SNIPR Biome Limited, alongside co-investors LSP, North-East Family Office and Wellington Partners.

SNIPR Biome is pioneering its proprietary CRISPR technology to revolutionise the treatment of microbial diseases. The constructs developed by SNIPR can subvert elements of the endogenous bacterial CRISPR machinery to targetedly eliminate hazardous bacteria in vivo. SNIPR have shown its constructs can be used in a highly specific manner, marking a significant and exciting development in the field.

Gill Jennings & Every LLP provided advice on the IP-related aspects of the transaction. The GJE team was led by partner John Jappy, assisted by Claire Windle.

GJE has a dedicated investor group, focused on understanding the needs of today’s investors and developing services to meet those needs. See here for more information.

Get in touch

If you are an ambitious business and you expect an IP service provider that can understand and help you achieve your commercial objectives, then we want to work with you. Complete the enquiry form below and one of our specialists will be in touch within one working day. Alternatively you can call us on +44 (0)20 7655 8500. We look forward to hearing from you.